Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
Kuan‐Sheng Wu, Pei‐Chin Lin, Yao-Shen Chen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 874-884
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Parham Sadeghipour, Behnood Bikdeli, Azita H. Talasaz, et al.
BMJ (2022), pp. e068407-e068407
Open Access | Times Cited: 65
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target
Pasquale Ambrosino, Ilenia Calcaterra, Marco Mosella, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 812-812
Open Access | Times Cited: 52
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
Maria Chiara Pelle, Isabella Zaffina, Stefania De Luca, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1605-1605
Open Access | Times Cited: 34
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review
Andreea Fitero, Simona Bungău, Delia Mirela Ţiţ, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 33
Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with meta-regressions
Pasquale Ambrosino, Stefano Sanduzzi Zamparelli, Marco Mosella, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 3233-3248
Open Access | Times Cited: 27
The bidirectional interaction of COVID-19 infections and lipoproteins
Kenneth R. Feingold
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101751-101751
Open Access | Times Cited: 19
The Effect of Prior Use of Statins on the Severity of COVID-19 Disease
Hadi Hasani, Farzaneh Hamidi, Fatemeh Ahmadi-Forg, et al.
Critical Care Nursing Quarterly (2025) Vol. 48, Iss. 2, pp. 143-150
Closed Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Cholesterol-lowering Drugs for High-Risk Hypercholesterolemia Patients with COVID-19 While on Paxlovid™ Therapy
Alpo Vuorio, Petri T. Kovanen, Frederick J. Raal
Future Virology (2022) Vol. 17, Iss. 10, pp. 761-765
Open Access | Times Cited: 16
Effects of statin therapy in hospitalized adult COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Débora Pinheiro Xavier, Gabriel Cavalcante Lima, Lorena Gisele Ferreira Gomes, et al.
Einstein (São Paulo) (2023) Vol. 21
Open Access | Times Cited: 9
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
Morley D. Hollenberg, Murray Epstein
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 48-62
Open Access | Times Cited: 14
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S)
Timo Strandberg, Petri T. Kovanen, Donald M. Lloyd‐Jones, et al.
The Lancet (2024)
Closed Access | Times Cited: 2
The Value of Clinical Frailty Scale (CFS) as a Prognostic Tool in Predicting Mortality in COVID-19—A Retrospective Cohort Study
Magdalena Jachymek, Aleksandra Cader, Michał Ptak, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 12
Molecular modeling of the interaction of ligands with ACE2–SARS-CoV-2 spike protein complex
Meden F. Isaac-Lam
In Silico Pharmacology (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Vaccinations, cardiovascular drugs, hospitalization, and mortality in COVID-19 and Long COVID
Ashkan Dashtban, Mehrdad A. Mizani, Laura Pasea, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107155-107155
Open Access | Times Cited: 1
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial
Azita H. Talasaz, Parham Sadeghipour, Hooman Bakhshandeh, et al.
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 07, pp. 723-733
Open Access | Times Cited: 4
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
Pandora L. Wander, Elliott Lowy, Lauren A. Beste, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058363-e058363
Open Access | Times Cited: 7
Drug-drug interaction with oral antivirals for the early treatment of COVID-19
Alpo Vuorio, Frederick J. Raal, Petri T. Kovanen
International Journal of Infectious Diseases (2022) Vol. 127, pp. 171-172
Open Access | Times Cited: 6
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19
Yiran Rong, Swarnali Goswami, O Eriakha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e076195-e076195
Open Access | Times Cited: 3
Epicardial and pericoronary adipose tissue in severe COVID-19 infection
Pınar Türker Duyuler, Serkan Duyuler, Bekir Demirtaş, et al.
Acta Cardiologica (2021) Vol. 78, Iss. 4, pp. 451-458
Closed Access | Times Cited: 8
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study
Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7492-7492
Open Access | Times Cited: 5
Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseases
Ching-Chung Hsiao, Jih‐Kai Yeh, Yanrong Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top